Pages that link to "Q42945383"
Jump to navigation
Jump to search
The following pages link to Basal insulin substitution with glargine or continuous subcutaneous insulin infusion in adult type 1 diabetes patients-a randomized controlled trial (Q42945383):
Displaying 5 items.
- Comparison of continuous subcutaneous insulin infusion and insulin glargine-based multiple daily insulin aspart injections with preferential adjustment of basal insulin in patients with type 2 diabetes (Q34119580) (← links)
- Clinical Experience with Insulin Glargine in Type 1 Diabetes (Q34296834) (← links)
- Changes in Insulin Requirements From the Onset of Continuous Subcutaneous Insulin Infusion (CSII) Until Optimization of Glycemic Control (Q35682701) (← links)
- Comparison of insulin pump therapy (continuous subcutaneous insulin infusion) to alternative methods for perioperative glycemic management in patients with planned postoperative admissions (Q36605665) (← links)
- Comparison of a multiple daily insulin injection regimen (glargine or detemir once daily plus prandial insulin aspart) and continuous subcutaneous insulin infusion (aspart) in short-term intensive insulin therapy for poorly controlled type 2 diabete (Q36869489) (← links)